What is an end-to-end verification system?

20.12.2021

Question of the Week

In an end-to-end system, the pharmaceutical company assigns each package of a medicinal product with a unique identifier during the production process. The data for the unique identifier is uploaded to the central database of the pharmaceutical industry and stored there. For the verification of authenticity, the data matrix code can for example be scanned before the product is dispensed to the patient.

[GMP Compliance Adviser, Chapter 21.H]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

24.11.2025

Question of the Week

How is a QRM process initiated?

You can view the answer here:

FDA: Updated Pre-RFD Guidance for Combination Products

The U.S. FDA has released an updated final guidance on preparing a Pre-Request for Designation (Pre-RFD), replacing the previous 2018 version. The revised document provides new recommendations for interacting with the Office of Combination Products (OCP) and clarifies expectations for Pre-RFD submissions.

EDQM: 9 Virtual Training Modules on Ph. Eur. and CEPs

The EDQM has introduced a modular training programme covering chemically defined active substances and medicinal products. It will take place between 1 and 12 December 2025.